Rachel Tanos, Ph.D. - Publications
Affiliations: | 2012 | Biochemistry and Molecular Biology | Pennsylvania State University, State College, PA, United States |
Area:
Biochemistry, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2019 | Muku GE, Kusnadi A, Kuzu G, Tanos R, Murray IA, Gowda K, Amin S, Perdew GH. Selective Ah receptor modulators attenuate NPC1L1-mediated cholesterol uptake through repression of SREBP-2 transcriptional activity. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 31417158 DOI: 10.1038/S41374-019-0306-X | 0.652 | |||
2012 | Tanos R, Murray IA, Smith PB, Patterson A, Perdew GH. Role of the Ah receptor in homeostatic control of fatty acid synthesis in the liver. Toxicological Sciences : An Official Journal of the Society of Toxicology. 129: 372-9. PMID 22696238 DOI: 10.1093/Toxsci/Kfs204 | 0.621 | |||
2012 | Tanos R, Patel RD, Murray IA, Smith PB, Patterson AD, Perdew GH. Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner. Hepatology (Baltimore, Md.). 55: 1994-2004. PMID 22234961 DOI: 10.1002/Hep.25571 | 0.665 | |||
2011 | Smith KJ, Murray IA, Tanos R, Tellew J, Boitano AE, Bisson WH, Kolluri SK, Cooke MP, Perdew GH. Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism. The Journal of Pharmacology and Experimental Therapeutics. 338: 318-27. PMID 21493753 DOI: 10.1124/Jpet.110.178392 | 0.644 | |||
2011 | Murray IA, Flaveny CA, Chiaro CR, Sharma AK, Tanos RS, Schroeder JC, Amin SG, Bisson WH, Kolluri SK, Perdew GH. Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone. Molecular Pharmacology. 79: 508-19. PMID 21127131 DOI: 10.1124/Mol.110.069369 | 0.523 | |||
Show low-probability matches. |